Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters

Complementary Medicines
Database
Language
Affiliation country
Publication year range
1.
Brain ; 145(7): 2332-2346, 2022 07 29.
Article in English | MEDLINE | ID: mdl-35134125

ABSTRACT

Metabolism regulates neuronal activity and modulates the occurrence of epileptic seizures. Here, using two rodent models of absence epilepsy, we show that hypoglycaemia increases the occurrence of spike-wave seizures. We then show that selectively disrupting glycolysis in the thalamus, a structure implicated in absence epilepsy, is sufficient to increase spike-wave seizures. We propose that activation of thalamic AMP-activated protein kinase, a sensor of cellular energetic stress and potentiator of metabotropic GABAB-receptor function, is a significant driver of hypoglycaemia-induced spike-wave seizures. We show that AMP-activated protein kinase augments postsynaptic GABAB-receptor-mediated currents in thalamocortical neurons and strengthens epileptiform network activity evoked in thalamic brain slices. Selective thalamic AMP-activated protein kinase activation also increases spike-wave seizures. Finally, systemic administration of metformin, an AMP-activated protein kinase agonist and common diabetes treatment, profoundly increased spike-wave seizures. These results advance the decades-old observation that glucose metabolism regulates thalamocortical circuit excitability by demonstrating that AMP-activated protein kinase and GABAB-receptor cooperativity is sufficient to provoke spike-wave seizures.


Subject(s)
Epilepsy, Absence , Hypoglycemia , AMP-Activated Protein Kinases/metabolism , Epilepsy, Absence/metabolism , Humans , Hypoglycemia/chemically induced , Hypoglycemia/metabolism , Receptors, GABA-B/metabolism , Seizures , Thalamus
2.
Elife ; 92020 09 09.
Article in English | MEDLINE | ID: mdl-32902384

ABSTRACT

Absence seizures result from 3 to 5 Hz generalized thalamocortical oscillations that depend on highly regulated inhibitory neurotransmission in the thalamus. Efficient reuptake of the inhibitory neurotransmitter GABA is essential, and reuptake failure worsens human seizures. Here, we show that blocking GABA transporters (GATs) in acute rat brain slices containing key parts of the thalamocortical seizure network modulates epileptiform activity. As expected, we found that blocking either GAT1 or GAT3 prolonged oscillations. However, blocking both GATs unexpectedly suppressed oscillations. Integrating experimental observations into single-neuron and network-level computational models shows how a non-linear dependence of T-type calcium channel gating on GABAB receptor activity regulates network oscillations. Receptor activity that is either too brief or too protracted fails to sufficiently open T-type channels necessary for sustaining oscillations. Only within a narrow range does prolonging GABAB receptor activity promote channel opening and intensify oscillations. These results have implications for therapeutics that modulate inhibition kinetics.


Subject(s)
Calcium Channels, T-Type/metabolism , Models, Neurological , Neurons/physiology , Thalamus/physiology , Animals , Cells, Cultured , GABA Plasma Membrane Transport Proteins/metabolism , Male , Rats , Rats, Sprague-Dawley , Receptors, GABA-B/metabolism , Seizures/metabolism
3.
Brain Res ; 1703: 41-52, 2019 01 15.
Article in English | MEDLINE | ID: mdl-29288644

ABSTRACT

Voluntary hyperventilation triggers seizures in the vast majority of people with absence epilepsy. The mechanisms that underlie this phenomenon remain unknown. Herein, we review observations - many made long ago - that provide insight into the relationship between breathing and absence seizures.


Subject(s)
Epilepsy, Absence/metabolism , Hyperventilation/metabolism , Seizures/etiology , Brain/metabolism , Cerebral Cortex/metabolism , Humans , Respiration , Thalamus/metabolism
4.
J Neurosci ; 38(5): 1232-1248, 2018 01 31.
Article in English | MEDLINE | ID: mdl-29273603

ABSTRACT

Maintenance of a low intracellular Cl- concentration ([Cl-]i) is critical for enabling inhibitory neuronal responses to GABAA receptor-mediated signaling. Cl- transporters, including KCC2, and extracellular impermeant anions ([A]o) of the extracellular matrix are both proposed to be important regulators of [Cl-]i Neurons of the reticular thalamic (RT) nucleus express reduced levels of KCC2, indicating that GABAergic signaling may produce excitation in RT neurons. However, by performing perforated patch recordings and calcium imaging experiments in rats (male and female), we find that [Cl-]i remains relatively low in RT neurons. Although we identify a small contribution of [A]o to a low [Cl-]i in RT neurons, our results also demonstrate that reduced levels of KCC2 remain sufficient to maintain low levels of Cl- Reduced KCC2 levels, however, restrict the capacity of RT neurons to rapidly extrude Cl- following periods of elevated GABAergic signaling. In a computational model of a local RT network featuring slow Cl- extrusion kinetics, similar to those we found experimentally, model RT neurons are predisposed to an activity-dependent switch from GABA-mediated inhibition to excitation. By decreasing the activity threshold required to produce excitatory GABAergic signaling, weaker stimuli are able to propagate activity within the model RT nucleus. Our results indicate the importance of even diminished levels of KCC2 in maintaining inhibitory signaling within the RT nucleus and suggest how this important activity choke point may be easily overcome in disorders such as epilepsy.SIGNIFICANCE STATEMENT Precise regulation of intracellular Cl- levels ([Cl-]i) preserves appropriate, often inhibitory, GABAergic signaling within the brain. However, there is disagreement over the relative contribution of various mechanisms that maintain low [Cl-]i We found that the Cl- transporter KCC2 is an important Cl- extruder in the reticular thalamic (RT) nucleus, despite this nucleus having remarkably low KCC2 immunoreactivity relative to other regions of the adult brain. We also identified a smaller contribution of fixed, impermeant anions ([A]o) to lowering [Cl-]i in RT neurons. Inhibitory signaling among RT neurons is important for preventing excessive activation of RT neurons, which can be responsible for generating seizures. Our work suggests that KCC2 critically restricts the spread of activity within the RT nucleus.


Subject(s)
GABAergic Neurons/physiology , Reticular Formation/physiology , Signal Transduction/physiology , Thalamus/physiology , Animals , Chlorides/metabolism , Chlorides/pharmacology , Computer Simulation , Female , Male , Mice , Mice, Inbred C57BL , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/genetics , Receptors, GABA-A/physiology , Symporters/genetics , Symporters/physiology , K Cl- Cotransporters
5.
J Neurosci ; 35(4): 1481-92, 2015 Jan 28.
Article in English | MEDLINE | ID: mdl-25632125

ABSTRACT

Prevailing literature supports the idea that common general anesthetics (GAs) cause long-term cognitive changes and neurodegeneration in the developing mammalian brain, especially in the thalamus. However, the possible role of GAs in modifying ion channels that control neuronal excitability has not been taken into consideration. Here we show that rats exposed to GAs at postnatal day 7 display a lasting reduction in inhibitory synaptic transmission, an increase in excitatory synaptic transmission, and concomitant increase in the amplitude of T-type calcium currents (T-currents) in neurons of the nucleus reticularis thalami (nRT). Collectively, this plasticity of ionic currents leads to increased action potential firing in vitro and increased strength of pharmacologically induced spike and wave discharges in vivo. Selective blockade of T-currents reversed neuronal hyperexcitability in vitro and in vivo. We conclude that drugs that regulate thalamic excitability may improve the safety of GAs used during early brain development.


Subject(s)
Anesthesia, General , Cerebral Cortex , Neural Pathways/physiology , Thalamus , 4-Butyrolactone/pharmacology , Action Potentials/drug effects , Animals , Animals, Newborn , Benzamides/pharmacology , Calcium Channel Blockers/pharmacology , Cerebral Cortex/cytology , Cerebral Cortex/drug effects , Cerebral Cortex/growth & development , Dose-Response Relationship, Drug , Epilepsy/chemically induced , Epilepsy/physiopathology , Evoked Potentials, Somatosensory/drug effects , Evoked Potentials, Somatosensory/physiology , Excitatory Postsynaptic Potentials/drug effects , Female , In Vitro Techniques , Inhibitory Postsynaptic Potentials/drug effects , Male , Neural Pathways/drug effects , Neurons/drug effects , Neurons/physiology , Piperidines/pharmacology , Rats , Rats, Sprague-Dawley , Thalamus/cytology , Thalamus/drug effects , Thalamus/growth & development
6.
J Neurosci ; 30(45): 15262-76, 2010 Nov 10.
Article in English | MEDLINE | ID: mdl-21068331

ABSTRACT

The long-lasting actions of the inhibitory neurotransmitter GABA result from the activation of metabotropic GABA(B) receptors. Enhanced GABA(B)-mediated IPSCs are critical for the generation of generalized thalamocortical seizures. Here, we demonstrate that GABA(B)-mediated IPSCs recorded in the thalamus are primarily defined by GABA diffusion and activation of distal extrasynaptic receptors potentially up to tens of micrometers from synapses. We also show that this diffusion is differentially regulated by two astrocytic GABA transporters, GAT1 and GAT3, which are localized near and far from synapses, respectively. A biologically constrained model of GABA diffusion and uptake shows how the two GATs differentially modulate amplitude and duration of GABA(B) IPSCs. Specifically, the perisynaptic expression of GAT1 enables it to regulate GABA levels near synapses and selectively modulate peak IPSC amplitude, which is primarily dependent on perisynaptic receptor occupancy. GAT3 expression, however, is broader and includes distal extrasynaptic regions. As such, GAT3 acts as a gatekeeper to prevent diffusion of GABA away from synapses toward extrasynaptic regions that contain a potentially enormous pool of GABA(B) receptors. Targeting this gatekeeper function may provide new pharmacotherapeutic opportunities to prevent the excessive GABA(B) receptor activation that appears necessary for thalamic seizure generation.


Subject(s)
Astrocytes/physiology , Inhibitory Postsynaptic Potentials/physiology , Receptors, GABA-B/physiology , Thalamus/physiology , gamma-Aminobutyric Acid/physiology , Animals , Electrophysiology , GABA Plasma Membrane Transport Proteins/physiology , Immunohistochemistry , Neural Inhibition/physiology , Neurons/physiology , Rats , Rats, Sprague-Dawley , Synapses/physiology
7.
J Neurophysiol ; 102(5): 2880-8, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19741104

ABSTRACT

The generation of prolonged neuronal activity depends on the maintenance of synaptic neurotransmitter pools. The astrocytic glutamate-glutamine cycle is a major mechanism for recycling the neurotransmitters GABA and glutamate. Here we tested the effect of disrupting the glutamate-glutamine cycle on two types of neuronal activity patterns in the thalamus: sleep-related spindles and epileptiform oscillations. In recording conditions believed to induce glutamine scarcity, epileptiform oscillations showed a progressive reduction in duration that was partially reversible by the application of exogenous glutamine (300 muM). Blocking uptake of glutamine into neurons with alpha-(methylamino) isobutyric acid (5 mM) caused a similar reduction in oscillation duration, as did blocking neuronal GABA synthesis with 3-mercaptoproprionic acid (10 muM). However, comparable manipulations did not affect sleep spindles. Together, these results support a crucial role for the glutamate-glutamine cycle in providing the neurotransmitters necessary for the generation of epileptiform activity and suggest potential therapeutic approaches that selectively reduce seizure activity but maintain normal neuronal activity.


Subject(s)
Action Potentials/physiology , Astrocytes/physiology , Glutamic Acid/metabolism , Glutamine/metabolism , Neurons/physiology , Thalamus/cytology , 3-Mercaptopropionic Acid/pharmacology , Action Potentials/drug effects , Analysis of Variance , Animals , Astrocytes/drug effects , Bicuculline/analogs & derivatives , Bicuculline/pharmacology , Convulsants/pharmacology , Female , Glutamic Acid/pharmacology , Glutamine/pharmacology , Male , Neurons/drug effects , Rats , Rats, Sprague-Dawley , Time Factors
8.
J Neurophysiol ; 102(1): 203-13, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19386752

ABSTRACT

Rhythmic oscillations throughout the cortex are observed during physiological and pathological states of the brain. The thalamus generates sleep spindle oscillations and spike-wave discharges characteristic of absence epilepsy. Much has been learned regarding the mechanisms underlying these oscillations from in vitro brain slice preparations. One widely used model to understand the epileptiform oscillations underlying absence epilepsy involves application of bicuculline methiodide (BMI) to brain slices containing the thalamus. BMI is a well-known GABAA receptor blocker that has previously been discovered to also block small-conductance, calcium-activated potassium (SK) channels. Here we report that the robust epileptiform oscillations observed during BMI application rely synergistically on both GABAA receptor and SK channel antagonism. Neither application of picrotoxin, a selective GABAA receptor antagonist, nor application of apamin, a selective SK channel antagonist, alone yielded the highly synchronized, long-lasting oscillations comparable to those observed during BMI application. However, partial blockade of SK channels by subnanomolar concentrations of apamin combined with picrotoxin sufficiently replicated BMI oscillations. We found that, at the cellular level, apamin enhanced the intrinsic excitability of reticular nucleus (RT) neurons but had no effect on relay neurons. This work suggests that regulation of RT excitability by SK channels can influence the excitability of thalamocortical networks and may illuminate possible pharmacological treatments for absence epilepsy. Finally, our results suggest that changes in the intrinsic properties of individual neurons and changes at the circuit level can robustly modulate these oscillations.


Subject(s)
Biological Clocks/physiology , Cerebral Cortex/physiology , Receptors, GABA-A/physiology , Small-Conductance Calcium-Activated Potassium Channels/physiology , Thalamus/physiology , Analysis of Variance , Animals , Animals, Newborn , Apamin/pharmacology , Bicuculline/analogs & derivatives , Bicuculline/pharmacology , Biological Clocks/drug effects , Cerebral Cortex/cytology , Cerebral Cortex/drug effects , Dose-Response Relationship, Drug , Drug Synergism , Electric Stimulation/methods , GABA Antagonists/pharmacology , In Vitro Techniques , Membrane Potentials/drug effects , Membrane Potentials/physiology , Neural Pathways/physiology , Patch-Clamp Techniques/methods , Picrotoxin/pharmacology , Potassium Channel Blockers/pharmacology , Rats , Rats, Sprague-Dawley , Small-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Thalamus/cytology , Thalamus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL